Skip to main content
. Author manuscript; available in PMC: 2013 Oct 15.
Published in final edited form as: Int J Pharm. 2012 Jun 9;436(1-2):127–134. doi: 10.1016/j.ijpharm.2012.05.038

Fig. 6.

Fig. 6

Influence of erlotinib and canertinib on plasma concentration profile of pazopanib after an i.v. bolus injection in FVB-wild type mice. Erlotinib and canertinib were administered intravenously 30 min prior to pazopanib through tail vein. Values are presented as mean ± S.E., n = 3.